Design, Synthesis and Pharmacological Evaluation of HIV-1 Reverse Transcriptase Inhibition of New Indolin-2-Ones

Author(s): Nubia Boechat, W. Bruce Kover, Vera Bongertz, Monica M. Bastos, Nelilma C. Romeiro, Maria L.G. Azevedo, Wagner Wollinger.

Journal Name: Medicinal Chemistry

Volume 3 , Issue 6 , 2007

Become EABM
Become Reviewer


The design, synthesis and anti HIV-1 replication inhibition of 3-(cyclopropylethynyl)-3-hydroxy-indolin-2- ones, analogues of efavirenz (Sustiva™), are described. Different substituted isatins were used to generate final products that contain pharmacophoric features for RT inhibition, such as the oxoindole and cyclopropylethynyl groups. The suitability of the indolin-2-one ring in the planned compounds in replacement to the benzoxazinone ring of efavirenz was proven, since compound 15 presented a greater activity than efavirenz against HIV-1 replication and was not significantly cytotoxic.

Keywords: Isatins, molecular modeling, efavirenz

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2007
Page: [533 - 542]
Pages: 10
DOI: 10.2174/157340607782360326
Price: $58

Article Metrics

PDF: 24